Ajanta pharma business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded generics business is spread in India and across Africa, CIS, the Middle East and South East Asia. In India compnay have presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management. Emerging markets are the major contributors in branded generic business where company present across Asia and Africa. Ajanta pharma have designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Ajanta Pharma are gradually building a meaningful presence in the US market with select product portfolio, which include complex technology products to get the competitive advantage in the market place. company expect US market to be our key growth driver in the coming years. Company’s Institutional business comprises of supplies to various government bodies in India and supply of Anti-Malarial products under WHO approved programs in Africa.